Developments in genomics offer opportunities to improve the way we detect risk factors for cardiovascular disease.
Theun van Veen from our Patient Safety and Care Improvement team assesses current testing capabilities and the obstacles to better detection.
His paper, Genetic hypercholesterolaemia and lipoprotein(a) – a call to better assess cardiovascular risk, argues our region is well placed to take advantage of the latest innovations in genomics.
Publications >
Powering the Future of Health and Care Innovation: our strategy 2026-2030 Read more
Powering the Future of Health and Care Innovation sets out our strategy until 2030.
For delivery teams: Introducing Neuro Rehabilitation Online (NROL) Read more
This case study shares lessons from scaling Neuro Rehabilitation Online (NROL), a digitally enabled group rehabilitation model for stroke and neurological services. It highlights the practical approaches, partnerships and leadership that supported successful NHS implementation and spread
For commissioners: Introducing Neuro Rehabilitation Online (NROL) Read more
This case study shows how Neuro Rehabilitation Online (NROL) scaled from a pilot to a commissioned NHS service, improving access to stroke rehabilitation through digitally enabled group therapy. It highlights the evidence, partnership approach and lessons that enabled successful adoption and scale-up.